TRIFLUPROMAZINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for triflupromazine and what is the scope of patent protection?
Triflupromazine
is the generic ingredient in one branded drug marketed by Apothecon and Bristol Myers Squibb, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for TRIFLUPROMAZINE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 2 |
| NDAs: | 3 |
| Drug Master File Entries: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| DailyMed Link: | TRIFLUPROMAZINE at DailyMed |
Medical Subject Heading (MeSH) Categories for TRIFLUPROMAZINE
Anatomical Therapeutic Chemical (ATC) Classes for TRIFLUPROMAZINE
US Patents and Regulatory Information for TRIFLUPROMAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | VESPRIN | triflupromazine hydrochloride | TABLET;ORAL | 011123-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | VESPRIN | triflupromazine hydrochloride | INJECTABLE;INJECTION | 011325-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Apothecon | VESPRIN | triflupromazine hydrochloride | INJECTABLE;INJECTION | 011325-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
